Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in a mouse model of radiation-induced cardiotoxicity.

Research square·2026
Same author

E Lesion or Stage IV disease? An Ongoing Unsettled Issue in Pediatric Hodgkin Lymphoma.

Blood advances·2026
Same author

Noisy probing dose facilitated dose prediction for pencil beam scanning proton therapy: Physics enhances generalizability.

Medical physics·2026
Same author

Technical Considerations on Proton Therapy in NRG's Multi-Institutional Clinical Trials.

International journal of radiation oncology, biology, physics·2026
Same author

Particle Therapy Co-Operative Group Consensus Statement on Reirradiation With Proton Therapy for Prostate Cancer.

International journal of particle therapy·2026
Same author

Characterization of Oncogenic and Immunogenic Profiling in Patients with Breast Cancer Tumors After Radiation Therapy.

International journal of molecular sciences·2026
Same journal

Validation of the Effectiveness of Visual Feedback Systems in Respiratory Gating Carbon Ion Radiation Therapy.

International journal of particle therapy·2026
Same journal

Emerging Outcome Trends From Proton Therapy for Pediatric CNS Tumors: A Systematic Review.

International journal of particle therapy·2026
Same journal

Biologically Effective Dose-Optimized Multi-Intensity-Modulated Proton Therapy: A Biologically Comparable Alternative to Proton Arc Therapy.

International journal of particle therapy·2026
Same journal

Proton Therapy for Head and Neck Adenoid Cystic Carcinoma: A Multi-institutional Review.

International journal of particle therapy·2026
Same journal

Characterization of a Low-Energy Cyclotron-Based Proton Beam for Preclinical Radiobiological Studies.

International journal of particle therapy·2026
Same journal

Phenomenological Study of Intra-Spill Break Spots in Dose-Driven Continuous Scanning Proton Therapy.

International journal of particle therapy·2026
See all related articles

Related Experiment Video

Updated: Oct 14, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K

Consensus Statement on Proton Therapy for Prostate Cancer.

Curtis M Bryant1, Randal H Henderson1, R Charles Nichols1

  • 1Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, FL, USA.

International Journal of Particle Therapy
|November 1, 2021
PubMed
Summary
This summary is machine-generated.

Proton therapy offers dosimetric advantages for prostate cancer but faces cost-effectiveness questions. This report guides clinical practice by examining its efficacy, safety, and value.

Keywords:
particle therapyprostate cancerproton therapyradiation therapy

More Related Videos

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.3K
Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

21.8K

Related Experiment Videos

Last Updated: Oct 14, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.6K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.3K
Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy
09:11

Use of MRI-ultrasound Fusion to Achieve Targeted Prostate Biopsy

Published on: April 9, 2019

21.8K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Proton therapy presents dosimetric benefits over photon therapy for prostate cancer.
  • Its higher cost raises concerns about its overall value and accessibility.
  • Existing studies show efficacy and safety for localized prostate cancer and post-surgical pelvic radiation.

Purpose of the Study:

  • To address current indications, advantages, and disadvantages of proton therapy for prostate cancer.
  • To evaluate the cost-effectiveness of proton therapy in prostate cancer management.
  • To review the current landscape of clinical trials involving proton therapy.

Main Methods:

  • Consensus report development by the Particle Therapy Co-Operative Group (PTCOG) Genitourinary Subcommittee.
  • Review of prospective and retrospective studies on proton therapy efficacy and safety.
  • Analysis of cost-effectiveness data and current clinical trial information.

Main Results:

  • Proton therapy demonstrates significant dosimetric advantages in prostate cancer treatment.
  • Evidence supports its efficacy and safety in various clinical scenarios, including localized disease and adjuvant/salvage settings.
  • Cost-effectiveness remains a key consideration, necessitating careful evaluation of patient and payer value.

Conclusions:

  • Proton therapy is a viable, albeit costly, option for prostate cancer management with proven benefits.
  • Further research and consensus are needed to optimize its clinical application and cost-effectiveness.
  • This report provides guidance for clinical practice and future research directions in proton therapy for prostate cancer.